{
    "2021-09-10": [
        [
            {
                "time": "",
                "original_text": "华兰生物：目前公司新冠灭活疫苗、鼻喷新冠减毒疫苗均处于临床前研究阶段，均未暂停",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "新冠灭活疫苗",
                        "鼻喷新冠减毒疫苗",
                        "临床前研究"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华兰生物(002007)受供应影响 血制品业务有所下降 全年血制品业务有望实现稳定增长",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "血制品业务",
                        "供应影响",
                        "稳定增长"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}